Department of Surgery, Kyung Hee University College of Medicine, Seoul, Korea.
Cancer Res Treat. 2008 Jun;40(2):75-80. doi: 10.4143/crt.2008.40.2.75. Epub 2008 Jun 30.
A 25% rate of recurrence after performing complete resection in node-negative colon cancer patients suggests that their nodal staging is frequently suboptimal. Moreover, the value of occult cancer cells in tumor-free lymph nodes still remains uncertain. The authors evaluated the prognostic significance of the pathologic parameters, including the lymph node occult disease (micrometastases) detected by immunohistochemistry, in patients with node-negative colon cancer.
The study included 160 patients with curatively resected stage I or II colon cancer and they were without rectal cancer. 2852 lymph nodes were re-examined by re-do hematoxylin and eosin (H-E) staining and immunohistochemical staining. The detection rates were compared with the clinicopathologic characteristics and with the cancer-specific survival.
Occult metastases were detected in 8 patients (5%). However, no clinicopathologic parameter was found to be correlated with the presence of micrometastasis. Twenty patients developed recurrence at a median follow-up of 45.7 months: 14 died of colon cancer and 9 died from noncancer-related causes. Univariate analysis showed that lymphatic invasion and the number of retrieved lymph nodes significantly influenced survival, and multivariate analysis revealed that the stage, the number of retrieved lymph nodes and lymphatic invasion were independently related to the prognosis.
Inadequate lymph node retrieval and lymphatic invasion were found to be associated with a poorer outcome for node-negative colon cancer patients. The presence of immunostained tumors cells in pN0 lymph nodes was found to have no significant effect on survival, but these tumor were identified by re-do H-E staining. Maximal attention should be paid to the total number of lymph nodes that are retrieved during surgery for colon cancer patients.
在淋巴结阴性的结肠癌患者中,完全切除后复发率为 25%,这表明其淋巴结分期常常不够理想。此外,肿瘤无转移的淋巴结中隐匿性癌细胞的价值仍不确定。作者评估了病理参数(包括免疫组化检测到的淋巴结隐匿性疾病(微转移))在淋巴结阴性结肠癌患者中的预后意义。
该研究纳入了 160 例经根治性切除的 I 期或 II 期结肠癌患者,且无直肠癌患者。对 2852 枚淋巴结进行重新苏木精-伊红(H-E)染色和免疫组化染色复查。比较检测结果与临床病理特征及癌症特异性生存的关系。
8 例(5%)患者检测到隐匿性转移。然而,未发现任何临床病理参数与微转移的存在相关。20 例患者在中位随访 45.7 个月时出现复发:14 例死于结肠癌,9 例死于非癌症相关原因。单因素分析显示,淋巴管浸润和检出的淋巴结数量显著影响生存,多因素分析显示,分期、检出的淋巴结数量和淋巴管浸润与预后独立相关。
检出的淋巴结取样不足和淋巴管浸润与淋巴结阴性结肠癌患者的不良预后相关。在 pN0 淋巴结中存在免疫染色肿瘤细胞与生存无显著相关性,但这些肿瘤可通过重新进行 H-E 染色发现。在为结肠癌患者进行手术时,应高度重视检出的淋巴结总数。